Skip to search formSkip to main contentSkip to account menu

technetium 99m EDDA-HYNIC-Tyr(3)-octreotide

Known as: 99mTc-EDDA-HYNIC-Tyr(3)-octreotide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
99mTc-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) is increasingly gaining acceptance as a new radiopharmaceutical for… 
2009
2009
Medullary thyroid carcinoma (MTC) is rare derived from C cells of the thyroid gland and represents approximately 5% of all… 
Review
2008
Review
2008
The imaging of neuroendocrine tumors has become one of the most significant areas in nuclear oncology. In an attempt to provide… 
Highly Cited
2007
Highly Cited
2007
The aim of this study was to evaluate the diagnostic value of a new somatostatin analog, 68Ga-labeled 1,4,7,10… 
Highly Cited
2006
Highly Cited
2006
PurposeAt all stages of the disease, serious difficulties are encountered in the imaging diagnosis of carcinoids. Somatostatin… 
2006
2006
PurposeDifferent attempts have been made to develop a suitable radioligand for targeting CCK-2 receptors in vivo, for staging of… 
Highly Cited
2005
Highly Cited
2005
PurposeThe aim of this study was to assess the value of multimodality imaging using a novel repositioning device with external… 
2005
2005
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of neuroendocrine tumours (NET… 
Highly Cited
2003
Highly Cited
2003
UNLABELLED The aim of this study was to compare the imaging abilities of the recently developed somatostatin analog, (99m)Tc…